To compare the effects of active limb mobilization (ALM) with or without electrical stimulation (ES) on muscle strength, respiratory rate (RR), heart rate, oxygen saturation, and time needed to transfer from bed to chair in two groups of patients with COPD. Design: Randomized, controlled study. Setting: Respiratory high-dependency care unit. Patients: Twenty-four bed-bound patients with chronic hypercapnic respiratory failure due to COPD who were receiving mechanical ventilation, with marked peripheral muscle hypotonia and atrophy. Methods: Patients were randomly assigned either to ALM alone or to ALM plus ES (ALM/ES). ES was applied using square-wave alternate, symmetric, and compensated impulses for 30 min bid. The duration of treatment was 28 days for all patients. Key words: COPD; electrical stimulation; exercise intolerance; rehabilitation; peripheral muscle dysfunction Abbreviations: ALM ϭ active limb mobilization; ALM/ES ϭ active limb mobilization plus electrical stimulation; ES ϭ electrical stimulation; HR ϭ heart rate; RR ϭ respiratory rate; Sat ϭ oxygen saturation P atients affected by COPD very frequently complain of exercise intolerance. 1 This exercise intolerance is usually attributed to abnormal lung mechanics, impaired gas exchange, and destruction of the pulmonary vascular bed, which all directly influence the capacity to sustain exercise. 2 However, patients with COPD often also have skeletal muscle dysfunction. [1] [2] [3] In 1992, Killian and colleagues 4 suggested the importance of peripheral skeletal muscle dysfunction on exercise capacity in patients with COPD. A few years later, Hamilton and colleagues 5 showed that approximately 70% of patients with chronic lung disease had less quadriceps strength than normal subjects of a similar age. Since skeletal muscle dysfunction can, fortunately, be a remediable source of exercise intolerance, 2 it is reasonable to speculate that rehabilitation could increase peripheral muscle function, thus increasing exercise tolerance. This has already been demonstrated to be the case both in normal subjects 6 and in patients with COPD 7, 8 ; however, the training strategies most commonly used in patients with COPD focused on lower-limb endurance training. 2 To the best of our knowledge, only two studies 9,10 gave an account of
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atients affected by COPD very frequently complain of exercise intolerance. 1 This exercise intolerance is usually attributed to abnormal lung mechanics, impaired gas exchange, and destruction of the pulmonary vascular bed, which all directly influence the capacity to sustain exercise. 2 However, patients with COPD often also have skeletal muscle dysfunction. [1] [2] [3] In 1992, Killian and colleagues 4 suggested the importance of peripheral skeletal muscle dysfunction on exercise capacity in patients with COPD. A few years later, Hamilton and colleagues 5 showed that approximately 70% of patients with chronic lung disease had less quadriceps strength than normal subjects of a similar age. Since skeletal muscle dysfunction can, fortunately, be a remediable source of exercise intolerance, 2 it is reasonable to speculate that rehabilitation could increase peripheral muscle function, thus increasing exercise tolerance. This has already been demonstrated to be the case both in normal subjects 6 and in patients with COPD 7, 8 ; however, the training strategies most commonly used in patients with COPD focused on lower-limb endurance training. 2 To the best of our knowledge, only two studies 9, 10 gave an account of the effects of strength training in patients with COPD; however, strength training is suggested as a rational component of exercise training during pulmonary rehabilitation. 11 The use of electrical stimulation (ES) has been proven to improve muscle strength. 12, 13 Moreover, it has been shown 12 that to reach an equivalent rate of muscle strengthening, a higher intensity of muscle contraction must be used during voluntary exercise than during ES. This may lead to an increase in heart rate (HR), particularly in elderly subjects. Using ES, a similar degree of muscular contraction can be reached without increasing cardiovascular work. 14 The primary aim of this study was to compare the effects of two different treatments on peripheral muscle strength. We also considered whether ES could effectively strengthen peripheral muscles without influencing cardiovascular function; for this reason, we studied respiratory rate (RR), HR, and oxygen saturation (Sat). Finally, we postulated that if the application of ES does improve peripheral muscle strength, this should influence the patients' functional ability; therefore, we looked for differences in the number of days needed to transfer from bed to chair. The patients were randomly assigned to receive the standard physical rehabilitation protocol of active limb mobilization (ALM) or ALM plus ES (ALM/ES).
Materials and Methods

Patients
The study group was a convenience sample formed of the first 24 subjects who met the inclusion criteria, consented to participate, and completed 28 days of the rehabilitation program. Our entry criteria were chronic hypercapnic respiratory failure due to COPD (the diagnosis of COPD was made according to the Global Initiative for Chronic Obstructive Lung Disease Workshop Report 15 ), need for invasive mechanical ventilation via a tracheostomy, and the presence of a severe peripheral muscle atrophy. All the patients were referred to our respiratory highdependency care unit from surrounding ICUs and had been confined to bed for at least 30 days. Subjects were considered eligible for the study if they were in a clinically stable state (ie, had no evidence of acute exacerbation and had no change in medications in the previous 4 weeks). Patients who had received inhaled steroids were enrolled in the study. Patients who had been treated with systemic corticosteroids and neuromuscular blocking agents for Ͼ 5 days while they were in the ICU were excluded. This is because it has been demonstrated that acute myopathy may occur in critically ill patients receiving corticosteroids with or without neuromuscular blocking agents, 16 and that a high dose of steroids for only 5 days, in the absence of other therapy, may induce serious respiratory and limb muscle weakness. 17 Exclusion criteria were a history of diseases other than COPD, in particular neurologic disease, and the need for treatment with systemic steroids during the rehabilitation period. The study was approved by the institutional ethics committees.
Measures
Primary Measures: Peripheral muscle strength was the primary outcome of this study and was evaluated at the beginning of the training and every 2 days during the rehabilitation program using a score commonly adopted in physical medicine. 18 This scoring system is shown in Table 1 . Muscle strength was evaluated independently by the referring physician and the chief therapist. Exercise training was performed by a member of the rehabilitation team who was unaware of the aim of the study. ALM of the upper and lower limbs was performed as soon as possible in all patients.
Twelve patients were randomly assigned to receive ALM/ES. The stimulator used was a commercially available two-channel model (SportTrainer; Actionfit; Forlì, Italy), which generated bipolar, biphasic, asymmetric rectangular pulses. Both ALM and ALM/ES were performed bid, 5 d/wk for 4 weeks, beginning with the maximum time tolerated by the patient and gradually increasing the time of training up to 30 min. Each ES session comprised 5 min at 8-Hz pulse width 250 microseconds and then 25 min at 35-Hz pulse width 350 microseconds. All treatment sessions took place on the patient's bed. Surface electrodes were bilaterally positioned on the quadriceps femoris and on vastus glutei.
Secondary Measures: Cardiorespiratory function and the number of days needed to transfer from bed to chair were recorded. Cardiorespiratory function included Sat, HR, and RR, which were acquired continuously using a monitoring system (S7010; Marquette Electronics; Milwaukee, WI).
Statistical Analysis
Results are expressed as mean Ϯ SD. Differences between the two groups were evaluated by paired Student t test. A p value Ͻ 0.05 was considered statistically significant.
Results
The patients' demographic and anthropometric characteristics and blood gas values are shown in Table 2 . All patients tolerated both ALM and ALM/ ES; nobody refused the procedures. There were no deaths during the study period. Eleven patients were successfully weaned from mechanical ventilation and tracheostomy, 7 patients were weaned from mechanical ventilation but were discharged with a tracheostomy, and 6 patients were discharged still receiving mechanical ventilation.
There were no statistically significant differences in baseline strength, HR, RR, and Sat between the Table 4 . The comparison of the change (ie, end minus beginning) in muscle strength and other variables between the two groups is shown in Table 5 . Compared to ALM alone, ALM/ES was able to further increase muscle strength (2.16 Ϯ 1.02 vs 1.25 Ϯ 0.75, p ϭ 0.02); moreover, ALM/ES was able to decrease RR (Ϫ 1.91 Ϯ 1.72 vs 0.41 Ϯ 1.88, p ϭ 0.004), while HR and Sat were not influenced. There was a significant difference in the number of days needed to transfer from bed to chair between patients treated with ALM/ES and those treated with only ALM (10.75 Ϯ 2.41 days vs 14.33 Ϯ 2.53 days, respectively; p ϭ 0.001).
Discussion
Exercise training is able to improve muscle strength even in bed-bound patients with COPD and a severe degree of functional impairment who are receiving mechanical ventilation. The addition of ES may further enhance the effects of classical rehabilitation treatment.
People with COPD are often confined to their house, isolated, and depressed as they try to avoid dyspnea. These features lead to significant debilitation, which further worsens dyspnea. Casaburi 1 pointed out that the list of effective therapies available for these patients is short, underlining that rehabilitative exercise training aimed at curing dysfunction of the peripheral muscles may be a proper addition to this short list. Among the possible mechanisms of muscle dysfunction, deconditioning is almost certainly a major contributor to the muscle dysfunction seen in patients with COPD. 1 Deconditioning causes substantial decreases in strength and endurance and can lead to atrophy of the muscles of ambulation. Dysfunction of the skeletal muscles, particularly the muscles of ambulation, contributes to the exercise intolerance that is a very frequent characteristic of patients with COPD. 19 Consequently, pulmonary rehabilitation and specifically rehabilitative exercise training ought to focus on exercise tolerance.
It has already been shown that pulmonary rehabilitation is able to improve exercise tolerance in patients with COPD. 19, 20 COPD is characterized by abnormal lung mechanics, impaired gas exchange, and destruction of the pulmonary vascular bed 2 ; since pulmonary rehabilitation obviously cannot affect these features, its effects have been attributed to psychological factors, including improved motivation and decreased sensitivity to dyspnea. 21 However, the role of pulmonary rehabilitation on skeletal muscles should not be underestimated; indeed, skeletal muscle dysfunction is a remediable source of exercise intolerance. 2 We decided to study bed-bound patients because we believe that they are the best model of extreme dysfunction of skeletal muscles. The fact that our patients were still receiving mechanical ventilation was a "guarantee" both of their severe functional impairment and that they had undergone a considerable period of immobility. The patients had been referred to our respiratory high-dependency care unit from surrounding ICUs for an attempt to wean them from mechanical ventilation and for pulmonary rehabilitation. Application of ES was decided after preliminary experience with a very small number of patients. 22 ALM of both upper and lower limbs was em- ployed, but ES was applied only to the lower limbs considering that upper-limb strength is relatively preserved in COPD, probably because the upperlimb muscles are more normally involved in activities of daily living. 2 Moreover, ES works on muscle strength, which is dramatically impaired in bed-bound patients. Surprisingly, muscle strength has been scarcely studied: COPD literature has almost exclusively focused on endurance activities. 3 Indeed, reduced endurance (ie, fatigue) seems to be the dominant limiting factor in peripheral muscles in these patients; however, the importance of muscle strength is now emerging. 23 It has been demonstrated 23 that the reduction in quadriceps strength averages 20 to 30% and that quadriceps strength correlates significantly with 6-min walking distance and maximal oxygen uptake in patients with COPD. 24 Moreover, muscle strength is significantly correlated with symptom intensity during incremental exercise testing. 4 Changes in muscle strength have been demonstrated to correlate significantly with changes in exercise capacity. 25 Peripheral muscle strength training has been shown to improve maximal muscle strength, exercise endurance capacity, and quality of life. 9 A editorial 26 on peripheral muscle wasting in COPD pointed out that probably the best available therapeutic modality to preserve muscle mass is strength training. In our patients, the first evaluations of muscle strength were made independently by both the referring physician and the chief therapist. The muscle strength score at hospital admission was low (1.75 Ϯ 0.73). According to the usual systems used for the evaluation of muscle strength, 18 this low score indicates that the evaluator can see a muscle contraction, but the patient is not able to move the joint unless gravity is eliminated. Using a score that considers the percentage of deficit and considering 0% the normal power, 27 our patients showed a muscle impairment ranging from 50 to 99%. This certifies their extreme degree of skeletal muscle dysfunction. It is important to emphasize that scores from 0 to 3 are objective scores. 27 Patients began exercise training as soon as possible (ie, when a stable clinical condition was reached) and both the duration and the intensity of the training were gradually increased. The training yielded a significant increase in muscle strength (3.44 Ϯ 0.65) in the whole population. This means that at the end of the training period, patients were able to move muscles against gravity. The degree of impairment at the end of the training ranged from 25 to 50%.
The addition of ES to the standardized therapy led to further significant improvements. Indeed, the muscle strength score was similar in the two groups at admission (Table 3) , but the final result was significantly different depending on which technique had been used; a higher score was reached when ES was added to ALM than when ALM was used alone. ES was administered during the period of exercise; once the electrostimulator had been applied, the therapist began the training exercises, handling the leg just during the electrical stimulation, so taking advantage of the impulses. In other words, the muscle contractions were stimulated by both the patient's voluntary movement and the electrical impulse.
Besides producing an additional increase in muscle strength, the combination of ALM and ES also shortened the time before the patient was able to transfer from bed to chair. This could lead to a decrease in complications associated with being bedridden, such as bedsores, pneumonia, and pulmonary embolism. Table 3 for definition of abbreviation. Table 3 for definition of abbreviation.
Limitation of the Study
We acknowledge that our study is somewhat limited by its small sample size; however, the sample was selected very carefully, adopting strict entry criteria, in order to exclude possible confounding variables. In particular, we tried to avoid any possible influence from drugs or other diseases that could have an effect on peripheral muscle strength. Our results confirm, in a larger population, what we found in a first investigation 22 and, therefore, we can speculate that is unlikely that significant discrepancies would emerge even with substantially larger numbers.
In conclusion, in bed-bound patients with severe COPD and still receiving invasive mechanical ventilation, ALM/ES improved peripheral muscle strength. This combined technique was well tolerated and, in comparison to ALM only, led to a reduction in RR. Patients were able to sit earlier than usual; this means an increase of functional ability and improvement of quality of life. The application of ES is safe, cheap, and reliable. It can be performed in any hospital setting, from the ICU to the general ward, and likely could shorten the duration of hospital stay in less severely ill patients.
